Science
MD Anderson’s Therapeutics Discovery Division, Orionis Biosciences Launch Project Helios to Advance Novel Small-Molecule Cancer Medicines – Press Release – Digital Journal
Combining Orionis’ unique high-throughput drug discovery technologies with the Therapeutics Discovery division’s expertise in small-molecule therapies and translational…
BOSTON & GHENT, Belgium & HOUSTON–(Business Wire)–Orionis Biosciences, a life sciences company pioneering innovation in genome-scale drug discovery, and The University of Texas MD Anderson Cancer Centers Therapeutics Discovery division today announced the launch of Project Helios, a research collaboration designed to unlock new drug development opportunities through genome-scale mapping of drug-target interactions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210309005121/en/
…
-
Noosa News20 hours agoTerrifying break-in at childcare centre on Sunshine Coast ends with death of man
-
General22 hours agoTrial of celebrity crocodile wrangler Matt Wright to hear from more witnesses
-
Noosa News21 hours agoWhy the Story Bridge won’t have a traffic lane repurposed for bikes and walkers
-
General23 hours agoPM kicks off roundtable with call for lasting reform